Ronald M. Klabe

2.6k citations

47 papers · 1.8k indexed · h-index 24

Co-authors: Susan Erickson‐Viitanen Beverly C. Cordova Lee T. Bacheler James D. Rodgers George L. Trainor Mona Patel Soo S. Ko Robert J. McHugh
Topics: HIV/AIDS drug development and treatment (38 papers)HIV Research and Treatment (27 papers)Biochemical and Molecular Research (17 papers)
Cited by: Virology Organic Chemistry Infectious Diseases
Journals: Journal of Biological Chemistry Biochemistry Cancer Research
Partner nations: United States Germany United Kingdom

In The Last Decade

Ronald M. Klabe

47 papers receiving 1.8k citations

Peers

Countries citing papers authored by Ronald M. Klabe

Since Specialization

Citations

This map shows the geographic impact of Ronald M. Klabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ronald M. Klabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ronald M. Klabe more than expected).

Fields of papers citing papers by Ronald M. Klabe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ronald M. Klabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ronald M. Klabe. The network helps show where Ronald M. Klabe may publish in the future.

Co-authorship network of co-authors of Ronald M. Klabe

This figure shows the co-authorship network connecting the top 25 collaborators of Ronald M. Klabe. A scholar is included among the top collaborators of Ronald M. Klabe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ronald M. Klabe. Ronald M. Klabe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase 2010 ·PubMed ·Elham Behshad,Ronald M. Klabe,Alexander R. Margulis,(unknown),Mark Rupar,Paul Collier,(unknown),Gregory Hollis,Timothy C. Burn,Richard Wynn	2
2	Isothiazolidinone inhibitors of PTP1B containing imidazoles and imidazolines 2007 ·Bioorganic & Medicinal Chemistry Letters ·Brent Douty,Brian Wayland,J. Paul,Michael J. Bower,James R. Pruitt,Lori L. Bostrom,Min Wei,Ronald M. Klabe,Lucie Gonneville,Richard Wynn,Timothy C. Burn,Phillip C.C. Liu,Andrew P. Combs,Eddy W. Yue	55
3	High-Throughput Determination of Mode of Inhibition in Lead Identification and Optimization 2007 ·SLAS DISCOVERY ·Min Wei,Richard Wynn,Gregory Hollis,(unknown),Alexander R. Margulis,Brian G. Reid,Ronald M. Klabe,Phillip C.C. Liu,(unknown),Mark Rupar,Timothy C. Burn,Dale E. McCall,(unknown)	23
4	Structural Basis for Inhibition of Protein-tyrosine Phosphatase 1B by Isothiazolidinone Heterocyclic Phosphonate Mimetics 2006 ·Journal of Biological Chemistry ·J. Paul,Lucie Gonneville,Milton C. Hillman,(unknown),Min Wei,Brian G. Reid,Ronald M. Klabe,Eddy W. Yue,Brian Wayland,Brent Douty,Padmaja Polam,Zelda R. Wasserman,Michael J. Bower,Andrew P. Combs,Timothy C. Burn,Gregory Hollis,Richard Wynn	61
5	Synthesis, antiviral activity and pharmacokinetics of P1/P1′ substituted 3-aminoindazole cyclic urea HIV protease inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Robert F. Kaltenbach,Mona Patel,Robert E. Waltermire,(unknown),(unknown),Ronald M. Klabe,Sena Garber,Lee T. Bacheler,Beverly C. Cordova,(unknown),Matthew Wright,Susan Erickson‐Viitanen,George L. Trainor	24
6	Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease 2001 ·Chemistry & Biology ·(unknown),Scott McN. Sieburth,Athanasios Glekas,(unknown),George L. Trainor,Susan Erickson‐Viitanen,Sena Garber,Beverly C. Cordova,(unknown),Ronald M. Klabe	67
7	Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of hIV-1 non-nucleoside reverse transcriptase 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,(unknown),(unknown),Beverly C. Cordova,Ronald M. Klabe,James D. Rodgers,Susan Erickson‐Viitanen	13
8	Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert J. McHugh,Beverly C. Cordova,Ronald M. Klabe,Lee T. Bacheler,Susan Erickson‐Viitanen,James D. Rodgers	81
9	Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor Efavirenz 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jay A. Markwalder,David D. Christ,Abdul Mutlib,Beverly C. Cordova,Ronald M. Klabe,Steven P. Seitz	12
10	Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,(unknown),Soo S. Ko,James D. Rodgers,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen	13
11	Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert J. McHugh,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,George L. Trainor,James D. Rodgers	78
12	Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1′ substituents 1999 ·Bioorganic & Medicinal Chemistry Letters ·Robert F. Kaltenbach,Ronald M. Klabe,Beverly C. Cordova,Steven P. Seitz	8
13	Thermodynamic linkage between the binding of protons and inhibitors to HIV‐1 protease 1999 ·Protein Science ·Joanna Trylska,Jan Antosiewicz,Maciej Geller,C. Nicholas Hodge,Ronald M. Klabe,Martha S. Head,Michael K. Gilson	60
14	Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2′ substituents 1999 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,James D. Rodgers,Robert J. McHugh,Barry L. Johnson,Beverly C. Cordova,Ronald M. Klabe,Lee T. Bacheler,Susan Erickson‐Viitanen,Soo S. Ko	53
15	Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors 1998 ·Chemistry & Biology ·James D. Rodgers,Patrick Y. S. Lam,Barry L. Johnson,Haisheng Wang,Soo S. Ko,Steven P. Seitz,George L. Trainor,Paul Anderson,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Sena Garber,Carol Reid,Matthew Wright,Chong‐Hwan Chang,Susan Erickson‐Viitanen	1
16	The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert F. Kaltenbach,David A. Nugiel,Robert J. McHugh,Prabhakar K. Jadhav,Lee T. Bacheler,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,Sena Garber,Carol Reid,Steven P. Seitz	19
17	Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2′ groups 1998 ·Bioorganic & Medicinal Chemistry Letters ·James D. Rodgers,Barry L. Johnson,(unknown),Susan Erickson‐Viitanen,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Chong‐Hwan Chang	34
18	The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P1/P1′ residues 1998 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Lee T. Bacheler,Marlene M. Rayner,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,Steven P. Seitz	16
19	Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors 1998 ·Chemistry & Biology ·James D. Rodgers,Patrick Y. S. Lam,(unknown),Haisheng Wang,(unknown),Steven P. Seitz,George L. Trainor,Paul Anderson,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Sena Garber,Carol Reid,Matthew Wright,(unknown),Susan Erickson‐Viitanen	32
20	A bis-[N-3-(1-hydroxy-1-methyl-ethyl)-benzyl)-cyclic urea as a HIV protease inhibitor 1995 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Gilbert N. Lam,Susan Erickson‐Viitanen,Lee T. Bacheler,Beverly C. Cordova,Ronald M. Klabe,James L. Meek	5

About Ronald M. Klabe

Ronald M. Klabe is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 47 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (38 papers), HIV Research and Treatment (27 papers) and Biochemical and Molecular Research (17 papers). The work is most often cited by research in Virology (471 citations), Organic Chemistry (1.0k citations) and Infectious Diseases (629 citations). Ronald M. Klabe has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Susan Erickson‐Viitanen, Beverly C. Cordova, Lee T. Bacheler, James D. Rodgers, George L. Trainor, Mona Patel, Soo S. Ko, Robert J. McHugh, Sena Garber and J. Paul. Their work appears in journals such as Journal of Biological Chemistry, Biochemistry and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact